Sodium glycerophosphate

DB09561ApprovedSmall molecule

Sodium glycerophosphate is a medication used to treat hypophosphatemia. It is used clinically to treat or prevent low phosphate levels.

Chemical structure of Sodium glycerophosphate
Mechanism
Curator reviewed · 1 reference
Primary indication
Sodium glycerophosphate is indicated for use as a source of phosphate in total parenteral nutrition.Curator reviewed · 1 structured indication
Formula / weight
C3H7Na2O6P · 216.036 g/mol (avg)
First approval
Canada, 2000 · United States, 2014
Also known as
Disodium glycerol phosphate
Brand names
  • Glycophos
  • Olimel
  • Periolimel

Resolves to

Compound
UNIIG43E72677UCAS1334-74-3ChEMBLCHEMBL3040581PubChem22251426
Clinical / RWD
RxNorm1595589ATCB05XA14
Structure
InChIKeyGEKBIENFFVFKRG-UHFFFAOYSA-LSMILES[Na+].[Na+].OCC(O)COP([O-])([O-])=O

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
16Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
173Marketed productsAcross 9 countries and 15 labellers
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Sodium glycerophosphate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In